An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

There isn't a cure for the condition, but doctors may recommend medications to slow down the progression of the disease or ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is unable to effectively use the insulin it produces ...

Mitochondrial defects, however, are associated with the development of diseases such as type 2 diabetes. Patients who suffer from this disorder are unable to produce enough insulin or use the insulin ...

Type 1 diabetes is a condition where our immune system destroys the insulin-making cells that exist in pancreas. These ...

The liver and pancreas are the main actors in glucose metabolism, but not the only ones. Muscles, adipose tissue and the brain play different roles. However, the prize for the best new actor in ...

Researchers at IISc Bengaluru discover potential drug-free treatment for diabetes by enhancing beta-cell function with small molecules.

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. The California ...